Consensus $2.57. Sees FY23 revenue up 1%-2%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BAX:
- BAX Earnings this Week: How Will it Perform?
- Notable open interest changes for October 13th
- Dialysis stocks ‘over-reacting’ to FLOW top-line results, says Wells Fargo
- UBS Calls DaVita (NYSE:DVA) Sell-Off “Big Overreaction”
- Dialysis stocks slide after Novo stops kidney outcomes trial early for efficacy